
MS is a disease of the central nervous system, estimated to affect 2.3 million people worldwide.
moreWith a strong and diverse portfolio covering the most common to the rarest neurological conditions, Roche is approaching neuroscience and rare disease with the same curiosity, passion and rigor as we have done in oncology. Our mission is rooted in our formula: follow the science to improve the lives of people.
MS is a disease of the central nervous system, estimated to affect 2.3 million people worldwide.
moreSMA affects approximately 1 in 10,000 live births worldwide. Find out more about the condition and the role of the SMN protein.
Downloads: Download
NMOSD is a rare and lifelong autoimmune disease of the central nervous system
moreBan katantaWe have so much to learn from each other about tackling the everyday challenges of spinal muscular atrophy. Find out how we can through SMA My Way.
moreLearn how we are breaking down barriers that prevent patients from joining clinical trials for spinal muscular atrophy.
moreBan katantaHow patient partnership is shaping the future of research and clinical development for Huntington’s disease.
moreAlzheimer’s disease is a progressive, fatal brain disease and the most common cause of dementia.
moreFind out more about this disease and how it impacts daily life?
Downloads: Download
Huntington’s disease can affect entire families, and much is still unknown about this complex brain disease, but through research, we hope to change that.
Kathy Hyde hopes that telling her son’s story will help increase understanding of the challenges faced by individuals with autism spectrum disorder.
more